[Federal Register Volume 69, Number 185 (Friday, September 24, 2004)]
[Notices]
[Page 57257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-21487]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Agricultural Research Service


Notice of Intent To Grant Exclusive License

AGENCY: Agricultural Research Service, USDA.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. Department of 
Agriculture, Agricultural Research Service, intends to grant to Hy-Gene 
Biomedical Corporation of Columbus, Ohio, an exclusive license to U.S. 
Patent No. 5,676,994, ``Non-Separable Starch-Oil Compositions,'' issued 
on October 14, 1997, and to U.S. Patent No. 5,882,713, ``Non-Separable 
Compositions of Starch and Water-Immiscible Organic Materials,'' issued 
on March 16, 1999, for all uses in the field of skin care and skin 
treatment products, including but not limited to drugs, devices, 
cosmetics and products for sanitizing surfaces. U.S. Patent No. 
5,676,994 is a continuation of U.S. Patent Application Serial No. 08/
233,173, and U.S. Patent No. 5,882,713 is a continuation-in-part of 
U.S. Patent Application Serial No. 08/233,173. Notice of Availability 
for U.S. Patent Application Serial No. 08/233,173 was published in the 
Federal Register on October 24, 1994.

DATES: Comments must be received within thirty (30) calendar days of 
the date of publication of this notice in the Federal Register.

ADDRESSES: Send comments to: USDA, ARS, Office of Technology Transfer, 
5601 Sunnyside Avenue, Room 4-1174, Beltsville, Maryland 20705-5131.

FOR FURTHER INFORMATION CONTACT: June Blalock of the Office of 
Technology Transfer at the Beltsville address given above; telephone: 
(301) 504-5989.

SUPPLEMENTARY INFORMATION: The Federal government's patent rights to 
this invention are assigned to the United States of America, as 
represented by the Secretary of Agriculture. It is in the public 
interest to so license this invention as Hy-Gene Biomedical Corporation 
has submitted a complete and sufficient application for a license. The 
prospective exclusive license will be royalty-bearing and will comply 
with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The 
prospective exclusive license may be granted unless, within thirty (30) 
days from the date of this published notice, the Agricultural Research 
Service receives written evidence and argument which establishes that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7.

Michael D. Ruff,
Assistant Administrator.
[FR Doc. 04-21487 Filed 9-23-04; 8:45 am]
BILLING CODE 3410-03-P